{
    "title": "U.S. FDA approves Acadia's Rett syndrome drug (March 10)",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11853975/U-S-FDA-approves-Acadias-genetic-Rett-syndrome-drug-March-10.html",
    "date": "2023-03-13",
    "keywords": [
        "drug",
        "approval",
        "nuplazid",
        "company",
        "use",
        "trofinetide",
        "price",
        "drugmaker",
        "development",
        "improvement",
        "treatment",
        "syndrome",
        "condition",
        "daybue",
        "loss",
        "fda",
        "psychosis",
        "disease",
        "growth",
        "acadia",
        "analyst",
        "launch",
        "latestage",
        "march",
        "food",
        "administration",
        "brain",
        "disorder",
        "friday",
        "health",
        "decision",
        "brand",
        "name",
        "adult",
        "age",
        "warning",
        "diarrhea",
        "term",
        "lot",
        "commercialization",
        "access",
        "executive",
        "kathie",
        "bishop",
        "end",
        "april",
        "david",
        "hoang",
        "capital",
        "gregory",
        "renza",
        "market",
        "year",
        "exclusivity",
        "indication",
        "schizophrenia",
        "earlystage",
        "candidate",
        "acp204",
        "retts",
        "government",
        "form",
        "factor",
        "igf1",
        "inflammation",
        "tissue",
        "aid",
        "transmission",
        "nerve",
        "application",
        "study",
        "core",
        "placebo",
        "assessment",
        "behaviour",
        "questionnaire",
        "impression",
        "payment",
        "neuron",
        "sale",
        "america",
        "reporting",
        "bhanvi",
        "satija",
        "srinivasan",
        "saligrama",
        "bengaluru",
        "editing",
        "kuber",
        "mallard"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}